Literature DB >> 29235189

Predictors of smoking cessation during pregnancy: a systematic review and meta-analysis.

Muhammad Riaz1, Sarah Lewis2, Felix Naughton3, Michael Ussher4.   

Abstract

AIM: To identify factors found in the research literature to be associated with smoking cessation in pregnancy.
METHODS: Electronic searches of the bibliographic databases of PubMed, EMBASE, PsycINFO, Elsevier, Scopus and ISI Web of Science were conducted to April 2017. All studies reporting factors associated with smoking cessation or continuing smoking during pregnancy were included and reviewed systematically, irrespective of study design. The Newcastle-Ottawa Quality Assessment Scale was used to assess the study quality. The DerSimonian & Laird random-effects model was used to conduct meta-analyses, and where effect estimates were reported for factors included in at least three studies.
RESULTS: Fifty-four studies, including 505 584 women globally who smoked before pregnancy, 15 clinical trials and 40 observational studies, were included in the review and 36 (65.5%) were considered to be of high quality. This review identified 11 socio-demographic, seven socially related, 19 smoking behaviour-related, five pregnancy-related, six health-related and six psychological factors that were associated significantly with smoking cessation during pregnancy. The most frequently observed significant factors associated with cessation were: higher level of education, pooled odds ratio (OR), 95% confidence interval (CI) = 2.16 (1.80-2.84), higher socio-economic status: 1.97 (1.20-3.24), overseas maternal birth: 2.00 (1.40-2.84), Medicaid coverage or private insurance: 1.54 (1.29-1.85), living with partner or married: 1.49 (1.38-1.61), partner/other members of the household do not smoke: 0.42 (0.35-0.50), lower heaviness of smoking index score: 0.45 (0.27-0.77, lower baseline cotinine level: 0.78 (0.64-0.94), low exposure to second-hand smoking: 0.45 (0.20-1.02), not consuming alcohol before and/or during pregnancy: 2.03 (1.47-2.80), primiparity: 1.85 (1.68-2.05), planned breastfeeding:1.99 (1.94-2.05), perceived adequate pre-natal care: 1.74 (1.38-2.19), no depression: 2.65 (1.62-4.30) and low stress during pregnancy: 0.58 (0.44-0.77).
CONCLUSION: A wide range of socio-demographics, relationship, social, smoking-related, pregnancy-related, health and psychological factors have been found to predict smoking cessation in pregnancy.
© 2017 Society for the Study of Addiction.

Entities:  

Keywords:  Cessation; clinical trials; determinants; interventions; meta-analysis; observational studies; predictors; pregnancy; smoking; systematic review

Mesh:

Substances:

Year:  2018        PMID: 29235189     DOI: 10.1111/add.14135

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  45 in total

1.  The interaction of sociodemographic risk factors and measures of nicotine dependence in predicting maternal smoking during pregnancy.

Authors:  Alexandra N Houston-Ludlam; Kathleen K Bucholz; Julia D Grant; Mary Waldron; Pamela A F Madden; Andrew C Heath
Journal:  Drug Alcohol Depend       Date:  2019-03-26       Impact factor: 4.492

2.  Efficacy of a Texting Program to Promote Cessation Among Pregnant Smokers: A Randomized Control Trial.

Authors:  Kathryn I Pollak; Pauline Lyna; Xiaomei Gao; Devon Noonan; Santiago Bejarano Hernandez; Sonia Subudhi; Geeta K Swamy; Laura J Fish
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244

3.  Association of Tobacco Use During Pregnancy, Perceived Stress, and Depression Among Alaska Native Women Participants in the Healthy Pregnancies Project.

Authors:  Christi A Patten; Harry A Lando; Chris A Desnoyers; Joseph Klejka; Paul A Decker; Martha J Bock; Christine A Hughes; Lucinda Alexie; Rahnia Boyer; Kenneth Resnicow; Linda Burhansstipanov
Journal:  Nicotine Tob Res       Date:  2020-10-29       Impact factor: 4.244

4.  Parents' Self-efficacy for Tobacco Exposure Protection and Smoking Abstinence Mediate Treatment Effects on Child Cotinine at 12-Month Follow-up: Mediation Results from the Kids Safe and Smokefree Trial.

Authors:  Bradley N Collins; Stephen J Lepore; Jonathan P Winickoff; David W Sosnowski
Journal:  Nicotine Tob Res       Date:  2020-10-29       Impact factor: 4.244

5.  Changes in Multiple and Different Tobacco Product Use Behaviors in Women Before and During Pregnancy: An Analysis of Longitudinal Population Assessment of Tobacco and Health Data.

Authors:  Sooyong Kim
Journal:  Am J Prev Med       Date:  2020-08-20       Impact factor: 5.043

6.  Elevated maternal and child mortality among women with multiple DUI convictions compared with socio-demographically matched controls.

Authors:  Vivia V McCutcheon; Kathleen K Bucholz; Alexandra N Houston-Ludlam; Andrew C Heath
Journal:  Addiction       Date:  2019-08-22       Impact factor: 6.526

7.  Smoke-Free Moms: Financial Rewards for Smoking Cessation by Low-Income Rural Pregnant Women.

Authors:  Ardis L Olson; Maureen B Boardman; Deborah J Johnson
Journal:  Am J Prev Med       Date:  2019-04-17       Impact factor: 5.043

8.  Are empathic processes mechanisms of pregnancy's protective effect on smoking? Identification of a novel target for preventive intervention.

Authors:  Suena H Massey; Ryne Estabrook; Leiszle Lapping-Carr; Rebecca L Newmark; Jean Decety; Katherine L Wisner; Lauren S Wakschlag
Journal:  Soc Sci Med       Date:  2022-05-25       Impact factor: 5.379

9.  The Great Disrupter: Relationship of Alexithymia to Emotion Regulation Processes and Smoking among Pregnant Women.

Authors:  Braden K Linn; Paul R Stasiewicz; Jennifer Fillo; Clara M Bradizza
Journal:  Subst Use Misuse       Date:  2020-03-10       Impact factor: 2.164

10.  Stress- and smoke free pregnancy study protocol: a randomized controlled trial of a personalized eHealth intervention including heart rate variability-biofeedback to support pregnant women quit smoking via stress reduction.

Authors:  Willeke van Dijk; Mirjam Oosterman; Imke Jansen; Wieke de Vente; Anja Huizink
Journal:  BMC Public Health       Date:  2021-05-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.